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 1 Why get vaccinated?
Meningococcal disease is a serious illness caused by a 
type of bacteria called Neisseria meningitidis. It can lead 
to meningitis (infection of the lining of the brain and 
spinal cord) and infections of the blood. Meningococcal 
disease often occurs without warning — even among 
people who are otherwise healthy.
Meningococcal disease can spread from person to person 
through close contact (coughing or kissing) or lengthy 
contact, especially among people living in the same 
household.
There are at least 12 types of N. meningitidis, called 
“serogroups.” Serogroups A, B, C, W, and Y cause most 
meningococcal disease.
Anyone can get meningococcal disease but certain 
people are at increased risk, including:
•	 Infants younger than one year old
•	 Adolescents and young adults 16 through 23 years old
•	 People with certain medical conditions that affect the 
immune system
•	 Microbiologists who routinely work with isolates of 
N. meningitidis
•	 People at risk because of an outbreak in their 
community
Even when it is treated, meningococcal disease kills 
10 to 15 infected people out of 100. And of those who 
survive, about 10 to 20 out of every 100 will suffer 
disabilities such as hearing loss, brain damage, kidney 
damage, amputations, nervous system problems, or 
severe scars from skin grafts.
Meningococcal ACWY vaccines can help prevent 
meningococcal disease caused by serogroups A, C, W, 
and Y. A different meningococcal vaccine is available to 
help protect against serogroup B.
 2   Meningococcal ACWY Vaccines
There are two kinds of meningococcal vaccines 
licensed by the Food and Drug Administration (FDA) 
for protection against serogroups A, C, W, and Y: 
meningococcal conjugate vaccine (MenACWY) and 
meningococcal polysaccharide vaccine (MPSV4).
Two doses of MenACWY are routinely recommended 
for	adolescents	11	through	18	years	old:	the	first	dose	
at 11 or 12 years old, with a booster dose at age 16. 
Some adolescents, including those with HIV, should get 
additional doses. Ask your health care provider for more 
information.
In addition to routine vaccination for adolescents, 
MenACWY vaccine is also recommended for certain 
groups of people:
•	 People at risk because of a serogroup A, C, W, or Y 
meningococcal disease outbreak
•	 Anyone whose spleen is damaged or has been removed
•	 Anyone with a rare immune system condition called 
“persistent	complement	component	deficiency”
•	 Anyone taking a drug called eculizumab (also called 
Soliris®)
•	 Microbiologists who routinely work with isolates of 
N. meningitidis
•	 Anyone traveling to, or living in, a part of the world 
where meningococcal disease is common, such as 
parts of Africa
•	 College freshmen living in dormitories
•	 U.S. military recruits
Children between 2 and 23 months old, and people 
with certain medical conditions need multiple doses for 
adequate protection. Ask your health care provider about 
the number and timing of doses, and the need for booster 
doses.
MenACWY is the preferred vaccine for people in these 
groups who are 2 months through 55 years old, have 
received MenACWY previously, or anticipate requiring 
multiple doses.
MPSV4 is recommended for adults older than 55 who 
anticipate requiring only a single dose (travelers, or 
during community outbreaks).
ML-025476  (4/16)
 3  Some people should not get this vaccine
Tell the person who is giving you the vaccine:
•	 If you have any severe, life-threatening allergies. 
 
If you have ever had a life-threatening allergic reaction 
after a previous dose of meningococcal ACWY 
vaccine, or if you have a severe allergy to any part 
of this vaccine, you should not get this vaccine. Your 
provider can tell you about the vaccine’s ingredients.
•	 If you are pregnant or breastfeeding. 
 
There is not very much information about the 
potential risks of this vaccine for a pregnant woman 
or breastfeeding mother. It should be used during 
pregnancy only if clearly needed.
If you have a mild illness, such as a cold, you can 
probably get the vaccine today. If you are moderately or 
severely ill, you should probably wait until you recover. 
Your doctor can advise you.
 4 Risks of a vaccine reaction
With any medicine, including vaccines, there is a chance 
of side effects. These are usually mild and go away on 
their own within a few days, but serious reactions are 
also possible.
As many as half of the people who get meningococcal 
ACWY vaccine have mild problems following 
vaccination, such as redness or soreness where the shot 
was given. If these problems occur, they usually last for 
1 or 2 days. They are more common after MenACWY 
than after MPSV4.
A small percentage of people who receive the vaccine 
develop a mild fever.
Problems that could happen after any injected 
vaccine:
•	 People sometimes faint after a medical procedure, 
including vaccination. Sitting or lying down for about 
15 minutes can help prevent fainting, and injuries 
caused by a fall. Tell your doctor if you feel dizzy, or 
have vision changes or ringing in the ears.
•	 Some people get severe pain in the shoulder and have 
difficulty	moving	the	arm	where	a	shot	was	given.	This	
happens very rarely.
•	 Any medication can cause a severe allergic reaction. 
Such reactions from a vaccine are very rare, estimated 
at about 1 in a million doses, and would happen within 
a few minutes to a few hours after the vaccination.
As with any medicine, there is a very remote chance of a 
vaccine causing a serious injury or death.
The safety of vaccines is always being monitored. For 
more information, visit: www.cdc.gov/vaccinesafety/
 5  What if there is a serious reaction?
What should I look for?
•	 Look for anything that concerns you, such as signs of 
a severe allergic reaction, very high fever, or unusual 
behavior. 
 
Signs of a severe allergic reaction can include hives, 
swelling	of	the	face	and	throat,	difficulty	breathing,	
a fast heartbeat, dizziness, and weakness — usually 
within a few minutes to a few hours after the 
vaccination.
What should I do?
•	 If you think it is a severe allergic reaction or other 
emergency that can’t wait, call 9-1-1 and get to the 
nearest hospital. Otherwise, call your doctor.
•	 Afterward, the reaction should be reported to the 
“Vaccine Adverse Event Reporting System” (VAERS). 
Your	doctor	should	file	this	report,	or	you	can	do	it	
yourself through the VAERS web site at  
www.vaers.hhs.gov, or by calling 1-800-822-7967.
VAERS does not give medical advice.
 6  The National Vaccine Injury Compensation Program
The National Vaccine Injury Compensation Program 
(VICP) is a federal program that was created to 
compensate people who may have been injured by 
certain vaccines.
Persons who believe they may have been injured by a 
vaccine	can	learn	about	the	program	and	about	filing	a	
claim by calling 1-800-338-2382 or visiting the VICP 
website at www.hrsa.gov/vaccinecompensation. There 
is	a	time	limit	to	file	a	claim	for	compensation.
 7 How can I learn more?
•	 Ask your health care provider. He or she can give you 
the vaccine package insert or suggest other sources of 
information.
•	 Call your local or state health department.
•	 Contact the Centers for Disease Control and  
Prevention (CDC): 
- Call 1-800-232-4636 (1-800-CDC-INFO) or 
- Visit CDC’s website at www.cdc.gov/vaccines
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